Advances in mechanisms of asthma, allergy, and immunology in 2011

Joshua A. Boyce; Bruce Bochner; Fred D. Finkelman; Marc E. Rothenberg

doi:10.1016/j.jaci.2011.12.968

Advances in mechanisms of asthma, allergy, and immunology in 2011

Joshua A. Boyce, Bruce Bochner, Fred D. Finkelman, Marc E. Rothenberg

School of Medicine

Research output: Contribution to journal › Article › peer-review

41 Scopus citations

Abstract

2011 was marked by rapid progress in the identification of basic mechanisms of allergic disease and the translation of these mechanisms into human cell systems. Studies published in the Journal of Allergy and Clinical Immunology this year provided new insights into the molecular determinants of allergenicity, as well as the environmental, cellular, and genetic factors involved in sensitization to allergens. Several articles focused on mechanisms of allergen immunotherapy and the development of novel strategies to achieve tolerance to allergens. Additional studies identified substantial contributions from T _H 17-type cells and cytokines to human disease pathogenesis. Finally, new therapeutic applications of anti-IgE were identified. The highlights of these studies and their potential clinical implications are summarized in this review.

Original language	English (US)
Pages (from-to)	335-341
Number of pages	7
Journal	Journal of Allergy and Clinical Immunology
Volume	129
Issue number	2
DOIs	https://doi.org/10.1016/j.jaci.2011.12.968
State	Published - Feb 2012

Keywords

Galactose-α-1,3-galactose
Toll-like receptor
calcitonin gene-related peptide
cyclic AMP
dendritic cell
facilitated antigen binding
facilitated antigen presentation
genome-wide association study
interferon
lipopolysaccharide
toluidine diisothiocyanate
vascular endothelial growth factor

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1016/j.jaci.2011.12.968

Cite this

@article{fa526229d24c462fa3137322eb439024,

title = "Advances in mechanisms of asthma, allergy, and immunology in 2011",

abstract = " 2011 was marked by rapid progress in the identification of basic mechanisms of allergic disease and the translation of these mechanisms into human cell systems. Studies published in the Journal of Allergy and Clinical Immunology this year provided new insights into the molecular determinants of allergenicity, as well as the environmental, cellular, and genetic factors involved in sensitization to allergens. Several articles focused on mechanisms of allergen immunotherapy and the development of novel strategies to achieve tolerance to allergens. Additional studies identified substantial contributions from T H 17-type cells and cytokines to human disease pathogenesis. Finally, new therapeutic applications of anti-IgE were identified. The highlights of these studies and their potential clinical implications are summarized in this review.",

keywords = "Galactose-α-1,3-galactose, Toll-like receptor, calcitonin gene-related peptide, cyclic AMP, dendritic cell, facilitated antigen binding, facilitated antigen presentation, genome-wide association study, interferon, lipopolysaccharide, toluidine diisothiocyanate, vascular endothelial growth factor",

author = "Boyce, {Joshua A.} and Bruce Bochner and Finkelman, {Fred D.} and Rothenberg, {Marc E.}",

note = "Funding Information: Disclosure of potential conflict of interest: B. Bochner has received consulting fees from Sanofi-Aventis and United States Diagnostics Standards; has received research support from the NIAID, NHLBI, and the Dana Foundation ; and is Editor in Chief for the Up-to-Date Allergy & Immunology section. M. E. Rothenberg has equity interest in Cephalon; is a consultant and Chief Scientific Office for Immune Pharmaceuticals; has received research support from the National Institutes of Health, FAAN, and the Department of Defense ; is on the APFED Medical Advisory Board; and is on the International Eosinophil Society Executive Council. The rest of the authors declare that they have no relevant conflicts of interest. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",

year = "2012",

month = feb,

doi = "10.1016/j.jaci.2011.12.968",

language = "English (US)",

volume = "129",

pages = "335--341",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Mosby Inc.",

number = "2",

}

TY - JOUR

T1 - Advances in mechanisms of asthma, allergy, and immunology in 2011

AU - Boyce, Joshua A.

AU - Bochner, Bruce

AU - Finkelman, Fred D.

AU - Rothenberg, Marc E.

N1 - Funding Information: Disclosure of potential conflict of interest: B. Bochner has received consulting fees from Sanofi-Aventis and United States Diagnostics Standards; has received research support from the NIAID, NHLBI, and the Dana Foundation ; and is Editor in Chief for the Up-to-Date Allergy & Immunology section. M. E. Rothenberg has equity interest in Cephalon; is a consultant and Chief Scientific Office for Immune Pharmaceuticals; has received research support from the National Institutes of Health, FAAN, and the Department of Defense ; is on the APFED Medical Advisory Board; and is on the International Eosinophil Society Executive Council. The rest of the authors declare that they have no relevant conflicts of interest. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.

PY - 2012/2

Y1 - 2012/2

N2 - 2011 was marked by rapid progress in the identification of basic mechanisms of allergic disease and the translation of these mechanisms into human cell systems. Studies published in the Journal of Allergy and Clinical Immunology this year provided new insights into the molecular determinants of allergenicity, as well as the environmental, cellular, and genetic factors involved in sensitization to allergens. Several articles focused on mechanisms of allergen immunotherapy and the development of novel strategies to achieve tolerance to allergens. Additional studies identified substantial contributions from T H 17-type cells and cytokines to human disease pathogenesis. Finally, new therapeutic applications of anti-IgE were identified. The highlights of these studies and their potential clinical implications are summarized in this review.

AB - 2011 was marked by rapid progress in the identification of basic mechanisms of allergic disease and the translation of these mechanisms into human cell systems. Studies published in the Journal of Allergy and Clinical Immunology this year provided new insights into the molecular determinants of allergenicity, as well as the environmental, cellular, and genetic factors involved in sensitization to allergens. Several articles focused on mechanisms of allergen immunotherapy and the development of novel strategies to achieve tolerance to allergens. Additional studies identified substantial contributions from T H 17-type cells and cytokines to human disease pathogenesis. Finally, new therapeutic applications of anti-IgE were identified. The highlights of these studies and their potential clinical implications are summarized in this review.

KW - Galactose-α-1,3-galactose

KW - Toll-like receptor

KW - calcitonin gene-related peptide

KW - cyclic AMP

KW - dendritic cell

KW - facilitated antigen binding

KW - facilitated antigen presentation

KW - genome-wide association study

KW - interferon

KW - lipopolysaccharide

KW - toluidine diisothiocyanate

KW - vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=84856479897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856479897&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2011.12.968

DO - 10.1016/j.jaci.2011.12.968

M3 - Article

C2 - 22284930

AN - SCOPUS:84856479897

SN - 0091-6749

VL - 129

SP - 335

EP - 341

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 2

ER -

Advances in mechanisms of asthma, allergy, and immunology in 2011

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this